Robert M. Califf

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Regression modelling strategies for improved prognostic prediction

Frank E. Harrell, Kerry L. Lee, Robert M. Califf et al. · Statistics in Medicine · 1984 · 1.8K citations

Public Health, Biostatistics, Cardiology +17

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

Mark A. Hlatky, Robin Boineau, Michael B. Higginbotham et al. · The American Journal of Cardiology · 1989 · 1.7K citations

Nursing, Rehabilitation Medicine, Functional Assessment +15

Practice Standards for Electrocardiographic Monitoring in Hospital Settings

Barbara J. Drew, Robert M. Califf, Marjorie Funk et al. · Circulation · 2004 · 621 citations · Full text

Medicine, Cardiology, Pediatrics +17

Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

Keith A.A. Fox, Jonathan P. Piccini, Daniel Wojdyla et al. · European Heart Journal · 2011 · 614 citations

Medicine, Cardiology, Pharmacotherapy +14